Workflow
天士力: 内蒙古建中律师事务所关于天士力医药集团股份有限公司2025年第四次临时股东大会的法律意见书

Group 1 - The legal opinion letter confirms the legality and validity of the convening, holding procedures, and voting results of the company's fourth extraordinary general meeting of shareholders in 2025 [1][2][4] - The meeting was held on September 2, 2025, with a total of 1,086 shareholders and representatives present, representing 729,134,511 shares with voting rights, accounting for 51.3745% of the total voting shares [3][4] - The voting process combined on-site and online voting, with the online voting conducted through the Shanghai Stock Exchange's system during specified trading hours [2][3] Group 2 - The meeting's agenda included ordinary resolutions, which were passed with more than half of the voting shares present, and separate counting was conducted for small and medium investors [4] - The legal opinion concludes that all procedures, qualifications of attendees, and voting results comply with relevant laws, regulations, and the company's articles of association [4]